Medicines for children - The last century and the next

Archives of Disease in Childhood

Volumn 85, Issue 3, 2001, Pages 177-179

  Stephenson, T ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ARTICLE; CHILD; CHILD HEALTH CARE; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG MONITORING; DRUG RESEARCH; DRUG SAFETY; HEALTH CARE SYSTEM; HUMAN; INFANT; LICENSING; NEWBORN; NEWBORN INTENSIVE CARE; PATIENT INFORMATION; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG APPROVAL; DRUG THERAPY; DRUG UTILIZATION; HUMANS; INFANT; INFANT, NEWBORN; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; RESEARCH SUPPORT;

EID: 0034822954     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.85.3.177     Document Type: Article

References (36)

1. Implications of the Crown Report and nurse prescribing
2. Use of "off label" and unlicensed drugs in paediatric intensive care unit
3. Unlicensed and off label drug use in paediatric wards: Prospective study
4. Unlicensed and off label drug use in neonates
5. Unlicensed and off label drug use in general practice
6. Off label and unlicensed drug use among French office based paediatricians
7. Adverse reactions to unlicensed and off-label drugs on paediatric wards
8. Birth of a formulary
9. The readability of patient information leaflets
10. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use
11. Ethical dilemmas of diagnosis and intervention
12. Ethics of randomised controlled trials
13. Support for studies in paediatric medicine is needed
14. Worst outcome of Griffiths report would be that research becomes increasingly difficult
15. Who is speaking for children and adolescents and for their health at the policy level?
16. The uncertainty principle and industry-sponsored research
17. Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial
18. UK paediatric clinical research under threat
19. Drug trials in children: Problems and the way forward
20. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: A randomised trial